Patients with antiphospholipid syndrome, either primary or associated with other connective tissue diseases, may develop a broad spectrum of pulmonary diseases. The most common complications are pulmonary thromboembolism and pulmonary hypertension; other complications such as microvascular pulmonary thrombosis, alveolar hemorrage, acute respiratory distress syndrome, fibrosing alveolitis has been also reported. The therapeutic approach in these patients do not differ from other complications of antiphospholipid syndrome, with the mandatory use of oral anticoagulant. In the case of pulmonary hypertension secondary to thromboembolism a conservative surgical approach using thromboendarterectomy may be useful.
|Translated title of the contribution||The lung in the antiphospholipid syndrome|
|Number of pages||8|
|Journal||Progressi in Reumatologia|
|Publication status||Published - 2003|
ASJC Scopus subject areas